Healthcare Prescriptive Analytics Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Healthcare Prescriptive Analytics Market size was valued at USD 3.6 billion in 2023 and is estimated to witness 15.5% CAGR from 2024 to 2032. Prescriptive analytics involves the application of advanced data analysis and algorithms to healthcare data, enabling actionable insights and recommendations for optimal decision-making. Prescriptive analytics provide specific guidance on actions to improve patient outcomes, operational efficiency, and overall healthcare processes, making it a vital tool for informed decision support in the healthcare industry.
The challenges during pandemic have reinforced the industry reliance on healthcare analytics to streamline essential operations. For instance, in June 2020, National Institutes of Health (NIH) initiated a healthcare data analytics platform for COVID-19 insights. The tool has emerged as a key component with broader implications for understanding clinical data in healthcare. It emphasized in guiding organizations by prescribing optimal actions based on datasets, surpassing the capabilities of predictive analytics. This increasing usage of analytics tools in healthcare setting is propelling the market expansion.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Healthcare Prescriptive Analytics Market size in 2023: | USD 3.6 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2023 - 2032 CAGR: | 15.5 |
2023 Value Projection: | USD 12.9 Billion |
Historical Data for: | 2018 - 2023 |
No of Pages: | 170 |
Tables, Charts & Figures: | 251 |
Segments Covered: | Component, Deployment Model, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
The growing focus on personalized and data-driven healthcare solutions has prompted healthcare providers to utilize prescriptive analytics. This approach empowered the providers to make informed personalized decisions, ultimately optimizing the patient outcomes and operational efficiency.
Also, the demand for precise proposals based on data insights, coupled with advancements in technology and the growing volume of healthcare data, anticipates spurring the adoption of prescriptive analytics driving market expansion. For instance, in June 2023, Pyramid Analytics Decision Intelligence Platform introduced Tabulate and Solve extensions, for business and decision modelling in a unified platform. The key updates enhanced the accessibility and utility, making complex processes like business modelling and prescriptive analytics more user-friendly for both technical and non-technical users. This advancement aimed to propel the healthcare analytics sector and enhance capabilities across various industries. Thus, the continuous advancement in the analytics sectors serves as a catalyst for market growth.
Based on the component, the market is classified into software and services. The software segment is anticipated to maintain its dominance, generating revenue of USD 2.3 billion in 2023, and is expected to continue similar trend throughout the forecast period.
Based on deployment model, the healthcare prescriptive analytics market is classified into on-premise and cloud-based. The cloud-based model is expected to hold the highest market share of 57.8% in 2023.
Based on application, the healthcare prescriptive analytics market is classified into clinical management, financial management, operation management, and other applications. The clinical management is expected hold the highest throughout the forecast period.
Based on end-use, the healthcare prescriptive analytics market is classified into hospitals, clinics, and other end-users. The hospitals are anticipated to secure the largest market share in 2023 and is anticipated to show similar trend during the analysis period with a CAGR of 12.6%.
In 2023, North America secured a substantial market share in the global healthcare prescriptive analytics market and is expected to dominate throughout the forecast period.
The competitive landscape of the healthcare prescriptive analytics industry is characterized by the presence of established players vying for market share. Leading companies focus on strategic collaborations, innovative launches, and mergers to expand their market share. Key players prioritize technological advancements to offer cutting-edge solutions, addressing the growing demand for data-driven insights in healthcare.
Prominent players operating in the healthcare prescriptive analytics industry are as mentioned below:
Market, By Component
Market, By Deployment Model
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries:
AIMMS, Alteryx, Deerwalk Inc., FICO, Frontline Systems, Inc., GUROBI OPTIMIZATION, LLC., Health Catalyst, IBM Corporation, Optum, Inc., Oracle Corporation, River Logic, Inc., and SAS Institute Inc.
In 2023, North America secured a substantial share in the healthcare prescriptive analytics market and is expected to grow through 2032, owing to the presence of advanced healthcare infrastructure, widespread adoption of digital technologies, and a strong commitment to data-driven decision-making.
The software segment generated revenue of USD 2.3 billion in 2023 and will grow significantly through 2032 as healthcare organizations are increasingly prioritizing data-driven decision-making.
The global healthcare prescriptive analytics industry was valued at USD 3.6 billion in 2023 and is expected to reach USD 12.9 billion by 2032 as it provides specific guidance on actions to improve patient outcomes, operational efficiency, and overall healthcare processes.